ravulizumab-cwvz (ultomiris) Report issue

Biologics mAb Orphan Drug FDA Approved FDA
AACT Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$4890.9600

VA FSS

$6307.4600

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ravulizumab 300 mg / 30 mL (30 mL SOLUTION) $4890.9600 VA Big4
  • Ultomiris (1)
    		•  Alexion Pharmaceuticals Inc.
    ravulizumab 300 mg / 30 mL (30 mL SOLUTION) $6307.4600 VA FSS
  • Ultomiris (1)
    		•  Alexion Pharmaceuticals Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue